ED
SCHW

Exane Derivatives’s Charles Schwab SCHW Stock Holding History

Exane Derivatives’s Portfolio SCHW Stock Details SCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-113
Closed -$9.5K – 1081
2021
Q4 		$9.5K Sell
113
-890
-89% -$72K ﹤0.01% 593
2021
Q3 		$73.1K Sell
1,003
-147
-13% -$10.5K 0.02% 580
2021
Q2 		$82.6K Buy
1,150
+9
+0.8% +$637 0.02% 569
2021
Q1 		$74.4K Buy
+1,141
New +$69.2K 0.02% 465
2019
Q4 		– Sell
-575
Closed -$24K – 705
2019
Q3 		$24K Hold
575
– – ﹤0.01% 392
2019
Q2 		$23.1K Sell
575
-920
-62% -$40.1K ﹤0.01% 420
2019
Q1 		$63.9K Buy
+1,495
New +$67.5K 0.01% 325
2016
Q2 		– Sell
-2,058
Closed -$57.7K – 618
2016
Q1 		$57.7K Buy
+2,058
New +$54.3K 0.01% 290
2015
Q3 		– Sell
-2,703
Closed -$88.3K – 566
2015
Q2 		$88.3K Buy
+2,703
New +$85.4K 0.01% 258

Other funds holding SCHW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Exane Derivatives's SCHW Position: Q1 2022 in Review

Exane Derivatives sold out of Charles Schwab (SCHW) in Q1 2022, closing a stake of 113 shares — an estimated $9.5K sold.

Exane Derivatives first reported a position in SCHW in Q2 2015 and held it in 9 quarters. The position peaked at $88.3K in Q2 2015. 1,565 funds tracked by Wall St. Rank hold SCHW as of Q1 2022.

  • Exane Derivatives reported no remaining Charles Schwab position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 113 Charles Schwab shares in Q1 2022, an estimated $9.5K.
  • Exane Derivatives first reported a position in Charles Schwab in Q2 2015 and held it in 9 quarters.
  • Exane Derivatives's Charles Schwab position peaked at $88.3K in Q2 2015.
  • 1,565 funds tracked by Wall St. Rank held Charles Schwab as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.